insights_auto
Why is GALT up 2.98%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.11
arrow_upward
+2.98%(+0.090) 1D
Nov 17, 9:46:07 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.11
High
$3.20
Low
$3.05
Mkt. cap
313.64M
Avg. vol.
201.39K
Volume
13.32K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.11
High
$3.20
Low
$3.05
Mkt. cap
313.64M
Avg. vol.
201.39K
Volume
13.32K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
GuruFocus
·
19 hours ago
Galectin Therapeutics (GALT) Posts Q3 Earnings Beat with Narrower Loss
scanx.trade
·
1 day ago
Galectin Therapeutics Q3 Results: Loss narrows 69% YoY to $0.04 per share
The Manila Times
·
1 day ago
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com